Chinese biotech Ascletis rallies in HK debut, in test of new market rules
HONG KONG: Shares in Chinese biotech company Ascletis Pharma Inc rose as much as 6.4 percent on their debut in Hong Kong on Wednesday, in the first such listing in…
Safe Point expresses cautious optimism on national plan for safe injections
New Delhi: Hope floated for the advocates of National Swachha Injection Abhiyan with the launch of National Viral Hepatitis Control Program by the Government of India. But they have expressed…
To check counterfeit medications, the working group may vet a plan
To weed out the fake drugs from the market, India’ central drug regulator “The Central Drugs Standard Control Organization (CDSCO) “is making a working group to basically assess its proposition…
Sun Pharma recalls over 2,500 bottles of diabetes drug from US
The US arm of Sun Pharmaceutical Industries is recalling over 2,500 bottles of Metformin hydrochloride extended release tablets from Arizona on account of presence of foreign substance in one lot.…
‘New found’ faith in Generics giving Branded medicines run for money
New Delhi: Happiness is writ large on Indian healthcare, thanks to generic medicines catching up fast. Patients are in for an unprecedented savings on medicines. To put it in StayHappi…
P&G, J&J cut sanitary napkin prices by 2-3%
Mumbai: Leading sanitary napkin makers Procter & Gamble (P&G) and Johnson & Johnson (J&J) on Friday passed on to consumers the benefits of the GST exemption on feminine hygiene products.…
Abbott India quits MNC lobby, ties up with IPA
NEW DELHI: In what could be a major setback for the multinational pharmaceutical lobby in India, American drug maker Abbott has quit Organisation of Pharmaceutical Producers of India (OPPI) primarily…
China launches nationwide vaccine sector inspection after scandal
Beijing: China launches nationwide vaccine sector inspection after scandal China’s drug regulator said it has launched a nationwide inspection of vaccine production as authorities step up the response to a…
Panel recommends ban on 343 fixed dose combination medicines
NEW DELHI: In a move that could potentially deliver a big blow to pharmaceutical companies in India, an apex advisory board on drugs approved a report backing the health ministry’s…
AstraZeneca sues DRL on patent
AstraZeneca has filed a lawsuit in the Delhi High Court against Indian drug maker Dr Reddy’s Laboratories to block it from launching generic versions of Brilinta, its blockbuster medicine for…
